Your session is about to expire
← Back to Search
Device
ABS deployed and active for Prosthesis Infections
N/A
Waitlist Available
Led By Sean Self
Research Sponsored by Nimbic Systems, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one-year post surgery
Awards & highlights
Study Summary
This is a prospective, randomized, blinded clinical trial to determine if the Air Barrier System device reduces the incidence of surgical site infection after total hip replacement, acetabular repair, posterior spinal fusion, and prosthetic vascular graft procedures.
Eligible Conditions
- Prosthesis Infections
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ one-year post surgery
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one-year post surgery
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Clinical incidence of surgical site infection
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: ABS deployed and activeExperimental Treatment1 Intervention
Air Barrier System (ABS) will be deployed onto the surgical field and activated.
Group II: ABS deployed and NOT activePlacebo Group1 Intervention
Air Barrier System (ABS) will be deployed onto the surgical field and NOT activated. This is a sham comparator to reduce the influence of the presence of the device and provide user blinding.
Find a Location
Who is running the clinical trial?
Nimbic Systems, LLCLead Sponsor
6 Previous Clinical Trials
473 Total Patients Enrolled
Sean SelfPrincipal InvestigatorInvestigator
1 Previous Clinical Trials
41 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger